1. Lee Y, Sung JY, Kim H, Yong D, Lee K. 2017; Comparison of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry platform, ASTA MicroIDSys, with Bruker Biotyper for species identification. Ann Lab Med. 37:531–5. DOI:
10.3343/alm.2017.37.6.531. PMID:
28840993. PMCID:
PMC5587828.
Article
2. Lee H, Park JH, Oh J, Cho S, Koo J, Park IC, et al. 2019; Evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of yeast isolation. J Clin Lab Anal. 33:e22685. DOI:
10.1002/jcla.22685. PMID:
30298531. PMCID:
PMC6818552.
Article
3. Kim D, Ji S, Kim JR, Kim M, Byun JH, Yum JH, et al. 2020; Performance evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, ASTA MicroIDSys system, in bacterial identification against clinical isolates of anaerobic bacteria. Anaerobe. 61:102131. DOI:
10.1016/j.anaerobe.2019.102131. PMID:
31778809.
Article
4. Jung J, Kim SY, Park YJ, Lee J, Suk HS, Ha SI, et al. 2020; Comparison of the ASTA MicroIDSys and VITEK MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry systems for identification of clinical bacteria and yeasts. J Infect Chemother. 26:1328–33. DOI:
10.1016/j.jiac.2020.08.004. PMID:
32855038.
Article
5. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. 2009;
Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 53:41–4. DOI:
10.1111/j.1348-0421.2008.00083.x. PMID:
19161556.
6. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. 2009;
Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 48:e57–61. DOI:
10.1086/597108. PMID:
19193113.
7. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. 2011; First three reported cases of nosocomial fungemia caused by
Candida auris. J Clin Microbiol. 49:3139–42. DOI:
10.1128/JCM.00319-11. PMID:
21715586. PMCID:
PMC3165631.
8. Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki M, Roodgari S, et al. 2019;
Candida auris otomycosis in Iran and review of recent literature. Mycoses. 62:101–5. DOI:
10.1111/myc.12886. PMID:
30585653.
9. Gade L, Muñoz JF, Sheth M, Wagner D, Berkow EL, Forsberg K, et al. 2020; Understanding the emergence of multidrug-resistant
Candida: using whole-genome sequencing to describe the population structure of
Candida haemulonii species complex. Front Genet. 11:554. DOI:
10.3389/fgene.2020.00554. PMID:
32587603. PMCID:
PMC7298116.
Article
10. Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. 2019; Potential fifth clade of
Candida auris, Iran, 2018. Emerg Infect Dis. 25:1780–1. DOI:
10.3201/eid2509.190686. PMID:
31310230. PMCID:
PMC6711235.
11. Welsh RM, Sexton DJ, Forsberg K, Vallabhaneni S, Litvintseva A. 2019; Insights into the unique nature of the East Asian clade of the emerging pathogenic yeast
Candida auris. J Clin Microbiol. 57:e00007–19. DOI:
10.1128/JCM.00007-19. PMID:
30760535. PMCID:
PMC6440783.
Article
12. Kwon YJ, Shin JH, Byun SA, Choi MJ, Won EJ, Lee D, et al. 2019;
Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. J Clin Microbiol. 57:e01624–18. DOI:
10.1128/JCM.01624-18. PMID:
30728190. PMCID:
PMC6440790.
Article
13. Lima SL, Francisco EC, de Almeida Júnior JN, Santos DWCL, Carlesse F, Queiroz-Telles F, et al. 2020; Increasing prevalence of multidrug-resistant
Candida haemulonii species complex among all yeast cultures collected by a reference laboratory over the past 11 years. J Fungi (Basel). 6:110. DOI:
10.3390/jof6030110. PMID:
32679832. PMCID:
PMC7558365.
14. Lee HS, Shin JH, Choi MJ, Won EJ, Kee SJ, Kim SH, et al. 2017; Comparison of the Bruker Biotyper and VITEK MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry systems using a formic acid extraction method to identify common and uncommon yeast isolates. Ann Lab Med. 37:223–30. DOI:
10.3343/alm.2017.37.3.223. PMID:
28224768. PMCID:
PMC5339094.
Article
15. Pence MA, McElvania TeKippe E, Wallace MA, Burnham CA. 2014; Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur J Clin Microbiol Infect Dis. 33:1703–12. DOI:
10.1007/s10096-014-2115-x. PMID:
24800928.
Article
16. Cassagne C, Cella AL, Suchon P, Normand AC, Ranque S, Piarroux R. 2013; Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory. Med Mycol. 51:371–7. DOI:
10.3109/13693786.2012.720720. PMID:
22978312.
Article
17. Khot PD, Couturier MR, Wilson A, Croft A, Fisher MA. 2012; Optimization of matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis for bacterial identification. J Clin Microbiol. 50:3845–52. DOI:
10.1128/JCM.00626-12. PMID:
22993178. PMCID:
PMC3502975.
Article
18. Fraser M, Brown Z, Houldsworth M, Borman AM, Johnson EM. 2016; Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database. Med Mycol. 54:80–8. DOI:
10.1093/mmy/myv085. PMID:
26591008.
Article
19. Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, et al. 2017; Can multidrug-resistant
Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol. 55:638–40. DOI:
10.1128/JCM.02202-16. PMID:
27881617. PMCID:
PMC5277535.
20. Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, et al. 2018; Multiple introductions and subsequent transmission of multidrug-resistant
Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis. 18:1377–84. DOI:
10.1016/S1473-3099(18)30597-8. PMID:
30293877. PMCID:
PMC6556114.